Jennison Associates
ACET icon

Jennison Associates’s Adicet Bio ACET Stock Holding History

Jennison Associates’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-23,504
Closed -$23.3M – 619
2019
Q3 		$23.3M Sell
23,504
-1,635
-7% -$1.83M 0.02% 297
2019
Q2 		$28.7M Sell
25,139
-474
-2% -$430K 0.03% 292
2019
Q1 		$19.6M Buy
25,613
+6,505
+34% +$5.91M 0.02% 359
2018
Q4 		$18.4M Sell
19,108
-126
-0.7% -$166K 0.02% 369
2018
Q3 		$32.6M Buy
19,234
+9,392
+95% +$12.2M 0.03% 323
2018
Q2 		$10.1M Buy
9,842
+2,560
+35% +$2.76M 0.01% 469
2018
Q1 		$7.81M Buy
+7,282
New +$13.4M 0.01% 469

Other funds holding ACET

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jennison Associates's ACET Position: Q4 2019 in Review

Jennison Associates sold out of Adicet Bio (ACET) in Q4 2019, closing a stake of 23,504 shares — an estimated $23.3M sold.

Jennison Associates first reported a position in ACET in Q1 2018 and held it in 7 quarters. The position peaked at $32.6M in Q3 2018. 54 funds tracked by Wall St. Rank hold ACET as of Q4 2019.

  • Jennison Associates reported no remaining Adicet Bio position as of Q4 2019 after selling out during the quarter.
  • Jennison Associates sold 23,504 Adicet Bio shares in Q4 2019, an estimated $23.3M.
  • Jennison Associates first reported a position in Adicet Bio in Q1 2018 and held it in 7 quarters.
  • Jennison Associates's Adicet Bio position peaked at $32.6M in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2019.

Based on Jennison Associates's 13F filing for Q4 2019, filed 7 Feb 2020.